MAPI Research Trust provides reliable, comprehensive and up-to-date information services to research scientists, pharmaceutical companies, and governmental health agencies involved in the fields of Patient-Reported Outcomes (PRO) and Pharmaco-Epidemiology worldwide.
Home SERVICES Questionnaire Licensing
QUALIOST™ (Quality of Life Questionnaire in Osteoporosis) PDF Print E-mail
 
Developed by:
Marquis P. et al. for Servier, France

Objective:
The QUALIOST® was specifically designed to evaluate the repercussions of Post Menopausal Osteoporosis (PMO) on patient HRQL.

Copyright:
QUALIOST® is protected by copyright and international trademark registration, with all rights reserved to SERVIER .

Reference publication:

carre5 de la Loge C, Sullivan K, Pinkney R, Marquis P, Roux C, Meunier PJ. Cross-cultural validation and analysis of responsiveness of the QUALIOST: QUAlity of Life questionnaire In OSTeoporosis. Health Qual Life Outcomes. 2005 Nov 10;3(1):69.

carre5 Tosteson AN, Hammond CS. Quality-of-life assessment in osteoporosis: health-status and preference-based measures. Pharmacoeconomics. 2002;20(5):289-303.

carre5 Marquis P, Cialdella P, De la Loge C. Development and validation of a specific quality of life module in post-menopausal women with osteoporosis: the QUALIOST. Qual Life Res. 2001;10(6):555-66.

Conditions of use and translate the QUALIOST®:

1. Use and Translation Agreement:

User is required to complete and sign the " Use and Translation Agreement for the QUALIOST®" in which specific conditions of use and translate required by the copyright owner are detailed.

Important note: the QUALIOST® is a self-administered module consisting of 23 questions which complements the SF-36. The generic items (SF-36) along with the disease-specific items forms the whole QUALIOST®. The disease-specific items cannot be used as an independent instrument. Please refer to the user agreement.

2. User's fees:

carre6 Distribution fees is requested according to the study design and context of use of the questionnaire:

  1. Access is free of charge in the framework of not-funded academic research (1) and individual clinical practice,
  2. Access to QUALIOST® for a use in funded academic research (2) is subject to a distribution fee payable to MAPI Research Trust, of an amount of 250 (two hundred and fifty) Euro* per study plus an additional 20 (twenty) Euro per language version requested.
  3. Access to the QUALIOST® for a use in commercial studies (3) involving "for-profit" organizations is subject to a distribution fee payable to MAPI Research Trust , of an amount of 400 (four hundred) Euro* per study plus an additional 50 (fifty) Euro per language version requested.


* excluding VAT

(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.

(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.

(3) Commercial studies (industry, CRO, any for-profit companies)

Contact information:

MAPI Research Trust
Christelle Berne

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 66 82
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Please have the 'Use and Translation Agreement for the QUALIOST" completed, dated and signed and return one original copy to MAPI Research Trust by post. As soon as we receive it, we will process your request.


More information on QUALIOST® on PROQOLID


[ BACK ]
 

New questionnaires distributed by MAPI Research Trust

ADCPQ (Alzheimer’s Disease Caregiver Preference Questionnaire)  
Novartis Pharmaceuticals Corporation (USA)

FIS (Fatigue Impact Scale)
D-FIS (Daily Fatigue Impact Scale)
John Fisk (Canada)  

HIV-SQUAD (Symptom Quality of Life Adherence) Questionnaire ®
Abbott France (France) 

MOS-HIV (Medical Outcome Study-HIV Health Survey)
Albert Wu (USA)

MPQ (McGill Pain Questionnaire)
Ronald Melzack (Canada)

MPQ-SF (McGill Pain Questionnaire - Short Form)
Ronald Melzack (Canada)

Nausea Questionnaire 
Ronald Melzack (Canada)

ODI (Oswestry Disability Questionnaire)
Jeremy Fairbank (UK)

PHQ (Patient Health Questionnaire Screeners
Pfizer Inc. (USA)

PRAC-Test (PRAgmatic Content and face validity Test)
Mapi Values (France)

SF-MPQ-2 (Short-form McGill Pain Questionnaire)
Ronald Melzack (Canada) and IMMPACT (USA) 


To access our catalog, please click here.



Coming soon!

Crohn and Anti-tnf Treatment Satisfaction questionnaire
Abbott France (France)


For any information, please contact:
contact@mapi-trust.org